Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colestilan versus simvastatin in dialysis patients with dyslipidaemia
2007-003364-21Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lipid disorder comparing Colestilan, Simvastatin and Placebo withdrawal phase (3 arms). Primary endpoints: LDL-C change during placebo-controlled withdrawal and Non-inferiority to simvastatin on LDL-C reduction. Started Dec 2008; status: completed.
02
Drugs
colestilansimvastatin
03
Conditions
lipid disorder
Beyond the preview
Go deeper on 2007-003364-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003364-21.